98-22324. National Institute on Drug Abuse; Notice of Meeting  

  • [Federal Register Volume 63, Number 160 (Wednesday, August 19, 1998)]
    [Notices]
    [Page 44466]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-22324]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    National Institutes of Health
    
    
    National Institute on Drug Abuse; Notice of Meeting
    
        Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
    amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
    the National Advisory Council on Drug Abuse.
        The meeting will be open to the public as indicated below, with 
    attendance limited to space available. Individuals who plan to attend 
    and need special assistance, such as sign language interpretation or 
    other reasonable accommodations, should notify the Contact Person 
    listed below in advance of the meeting.
        The meeting will be closed to the pubic in accordance with the 
    provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
    U.S.C., as amended. The grant applications and the discussions could 
    disclose confidential trade secrets or commercial property such as 
    patentable material, and personal information concerning individuals 
    associated with the grant applications, the disclosure of which would 
    constitute a clearly unwarranted invasion of personal privacy.
    
        Name of Committee: National Advisory Council on Drug Abuse.
        Date: September 15-18, 1998.
        Closed: September 15, 1998, 2:00 PM to 5:00 PM.
        Agenda: To review and evaluate grant applications.
        Place: National Institutes of Health, Natcher Building, 45 
    Center Drive, Bethesda, MD 20982.
        Open: September 16, 1998, 9:00 AM to Adjournment.
        Agenda: This portion of the meeting will be open to the public 
    for announcements and reports of administrative, legislative and 
    program developments in the drug abuse field.
        Place: National Institutes of Health, Natcher Building, 45 
    Center Drive, Bethesda, MD 20982.
        Contact Person: Teresa Levitin, Director, Office of Extramural 
    Program Review, National Institute on Drug Abuse, National 
    Institutes of Health, DHHS, Bethesda, MD 20892.
    
    (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
    Abuse Scientist Development Award for Clinicians, Scientist 
    Development Awards, and Research Scientist Awards; 93.278, Drug 
    Abuse National Research Service Awards for Research Training; 
    93.279, Drug Abuse Research Programs, National Institutes of Health, 
    HHS)
    
        Dated: August 13, 1998.
    LaVerne Y. Stringfield,
    Committee Management Officer, NIH.
    [FR Doc. 98-22324 Filed 8-18-98; 8:45 am]
    BILLING CODE 4140-01-M
    
    
    

Document Information

Effective Date:
9/15/1998
Published:
08/19/1998
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
98-22324
Dates:
September 15-18, 1998.
Pages:
44466-44466 (1 pages)
PDF File:
98-22324.pdf